REGN vs. NVO
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or NVO.
Correlation
The correlation between REGN and NVO is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. NVO - Performance Comparison
Key characteristics
REGN:
-1.17
NVO:
-1.18
REGN:
-1.60
NVO:
-1.74
REGN:
0.80
NVO:
0.77
REGN:
-0.61
NVO:
-0.82
REGN:
-1.12
NVO:
-1.66
REGN:
29.62%
NVO:
29.58%
REGN:
28.44%
NVO:
41.60%
REGN:
-91.81%
NVO:
-70.96%
REGN:
-50.03%
NVO:
-56.52%
Fundamentals
REGN:
$64.01B
NVO:
$266.85B
REGN:
$38.50
NVO:
$3.49
REGN:
15.27
NVO:
17.56
REGN:
0.94
NVO:
0.89
REGN:
4.51
NVO:
0.92
REGN:
2.19
NVO:
12.30
REGN:
$11.06B
NVO:
$225.05B
REGN:
$9.40B
NVO:
$190.45B
REGN:
$3.94B
NVO:
$113.24B
Returns By Period
In the year-to-date period, REGN achieves a -15.69% return, which is significantly higher than NVO's -26.02% return. Over the past 10 years, REGN has underperformed NVO with an annualized return of 2.41%, while NVO has yielded a comparatively higher 10.45% annualized return.
REGN
-15.69%
-5.42%
-35.35%
-33.76%
1.19%
2.41%
NVO
-26.02%
-13.53%
-44.14%
-49.37%
15.98%
10.45%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. NVO — Risk-Adjusted Performance Rank
REGN
NVO
REGN vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. NVO - Dividend Comparison
REGN's dividend yield for the trailing twelve months is around 0.15%, less than NVO's 2.58% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.58% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
Drawdowns
REGN vs. NVO - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than NVO's maximum drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for REGN and NVO. For additional features, visit the drawdowns tool.
Volatility
REGN vs. NVO - Volatility Comparison
The current volatility for Regeneron Pharmaceuticals, Inc. (REGN) is 12.61%, while Novo Nordisk A/S (NVO) has a volatility of 16.91%. This indicates that REGN experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities